mHealth Intelligence October 12, 2018
Eric Wicklund

The FDA has granted market clearance to the FibriCheck mHealth app, which measures heart rhythm via a smartphone camera or smartwatch sensors and can be used to detect atrial fibrillation.

Federal officials have OK’d the first mHealth app capable of detecting atrial fibrillation.

The U.S. Food and Drug Administration recently granted market clearance for FibriCheck, a Belgium-based company whose mobile health app uses a smartphone camera or smartwatch sensors to measure one’s heartbeat. The process, called photoplethysmography, measures light reflection through blood flow.

FDA officials said this is the first approved mHealth app that detects heart rhythm disorders using only an optical signal originating from a non-medical device.

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Digital Health, FDA, Govt Agencies, mHealth, Technology
Apple’s latest AI research could completely transform your iPhone
New AI model aims to fix flaws in smartphone-based COVID-19 X-ray diagnosis
Apple can now assess your risk for depression, anxiety
Samsung, b.well partner to collect health data on Galaxy smartphones
Samsung, b.well partner to provide longitudinal data to Galaxy smartphone users

Share This Article